Search
Filters
Clear All
  • 19
  • 56
  • 2
  • 706

Phase

  • 1
  • 20
  • 20
  • 57
  • 6
  • 79
  • 5
  • 585
  • 698
  • 307
  • 765
  • 18

Found 783 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis (STTEPP)

E
Evan Fogel, MD
18 years or above
All genders
Phase 1
Interventional
The investigators propose to conduct a dose-escalation trial of an FDA-approved antiepileptic drug, lacosamide, added to opioid therapy in patients with chronic abdominal pain fromhronic pancreatitis (CP). This pilot trial will test the feasibility of the study design andvide reassurance regarding the tolerability and safety of lacosamide used concomitantly with …
Learn More

TArgeting Type 1 Diabetes Using POLyamines (TADPOL) (TADPOL)

E
Emily Sims, MD
6 years - 40 years
All genders
Phase 2
Interventional
The goal of this clinical trial is to test a drug known as DFMO in people with Type 1 Diabetes (T1D). The main question[s] it aims to answer are:Does it reduce stress on the cells that make insulin?Does it preserve what is left of the body's insulin production? Participants will …
Learn More

Gastroschisis Outcomes of Delivery (GOOD) Study

H
Hiba Mustafa, MD
18 years or above
Female
Phase 3
Interventional
The objective of this study is to investigate the hypothesis that delivery at 35 0/7- 35 6/7 weeks in stable patients with gastroschisis is superior to observation and expectantgement with a goal of delivery at 38 0/7 - 38 6/7 weeks. To test this hypothesis, we willdomized, prospective, multi-institutional trial …
Learn More

A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab (PROMISE-US)

K
Kassem Bourgi, MD
18 years or above
All genders
Observational
The virological efficacy of ibalizumab has been clearly demonstrated in multiple clinical. This study will expand ibalizumab's clinical data set and allow a better understanding of the virologic response durability on ARV regimens with or without ibalizumabheterogeneous real-world patient population. Additional data on the efficacy and safetybalizumab and its impact …
Learn More

Delirium and Neuropsychological Recovery Among Emergency General Surgery Survivors

M
Malaz Boustani, MD
65 years or above
All genders
Interventional
This study will evaluate the usefulness of the Emergency General Surgery (EGS) Delirium Recovery Model. It is hypothesized that the cognitive, physical and psychological recovery ofder EGS delirium survivors will be improved through the use of the EGS Delirium Recoverydel. Participants can expect to be on the study for 18 …
Learn More

Selatogrel Outcome Study in Suspected Acute Myocardial Infarction (SOS-AMI)

M
Mohammed Madmani, MD
R
Rolf Kreutz, MD
18 years or above
All genders
Phase 3
Interventional
This study will randomize patients recently discharged from the hospital with a confirmed diagnosis of type 1 acute myocardial infarction (Thygesen et al. 2018) and having additionaldiovascular risk factors.
Learn More

Citadel Embolization Device Study

B
Bradley N. Bohnstedt, MD
18 years - 80 years
All genders
Interventional
The purpose of this study is to gather preliminary safety and effectiveness data on Citadelbolization Device in the treatment of wide-neck intracranial aneurysms.
Learn More

Post-approval Study of Transcarotid Artery Revascularization in Standard Risk Patients With Significant Carotid Artery Disease

R
Raghu Motaganahalli, MD
18 years - 79 years
All genders
Observational
The study objective is to evaluate real world usage of the ENROUTE Transcarotid Stent when used with the ENROUTE Transcarotid Neuroprotection System in patients at standard risk fordverse events from carotid endarterectomy
Learn More

Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection (HIKO STEC)

M
Myda Khalid
9 months - 21 years
All genders
Phase 3
Interventional
The objective of this study is to determine if early high volume intravenous fluiddministration (hyperhydration) may be effective in mitigating or preventing complications ofhiga toxin-producing E. coli (STEC) infection in children and adolescents when compared withditional approaches (conservative fluid management).
Learn More

Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

S
Sandeep Batra, MD
1 month - 21 years
All genders
Phase 3
Interventional
What is the purpose of this study?Rhabdomyosarcoma is a type of cancer that occurs in the soft tissues in the body. This phaseutcomes in patients with very low risk rhabdomyosarcoma (VLR-RMS) while decreasing the burden of therapy using treatment with 24 weeks of vincristined dactinomycin (VA) and examines the use …
Learn More
391 - 400 of 783